On March 27, 2024, Ayala Pharmaceuticals, Inc. and Roy Golan, Chief Financial Officer, agreed that Mr. Golan would depart the Company on June 25, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.55 USD | -12.00% | +3.68% | -17.54% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.54% | 26.65M | |
+24.79% | 46.71B | |
+48.83% | 41.8B | |
-1.09% | 41.52B | |
-5.86% | 29.55B | |
+10.91% | 25.78B | |
-20.51% | 19.26B | |
+2.45% | 12.14B | |
-3.40% | 12.08B | |
+28.91% | 11.98B |
- Stock Market
- Equities
- ADXS Stock
- News Ayala Pharmaceuticals, Inc.
- Ayala Pharmaceuticals, Inc. Announces Departure of Roy Golan as Chief Financial Officer, Effective from June 25, 2024